Correlation Between Immunovant and 89bio
Can any of the company-specific risk be diversified away by investing in both Immunovant and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunovant and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunovant and 89bio Inc, you can compare the effects of market volatilities on Immunovant and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunovant with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunovant and 89bio.
Diversification Opportunities for Immunovant and 89bio
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Immunovant and 89bio is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Immunovant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunovant are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Immunovant i.e., Immunovant and 89bio go up and down completely randomly.
Pair Corralation between Immunovant and 89bio
Given the investment horizon of 90 days Immunovant is expected to generate 1.1 times less return on investment than 89bio. But when comparing it to its historical volatility, Immunovant is 1.33 times less risky than 89bio. It trades about 0.15 of its potential returns per unit of risk. 89bio Inc is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 740.00 in 89bio Inc on July 30, 2024 and sell it today you would earn a total of 47.00 from holding 89bio Inc or generate 6.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Immunovant vs. 89bio Inc
Performance |
Timeline |
Immunovant |
89bio Inc |
Immunovant and 89bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immunovant and 89bio
The main advantage of trading using opposite Immunovant and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunovant position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.Immunovant vs. Arbutus Biopharma Corp | Immunovant vs. Arcutis Biotherapeutics | Immunovant vs. Legend Biotech Corp | Immunovant vs. Protagonist Therapeutics |
89bio vs. Madrigal Pharmaceuticals | 89bio vs. Pliant Therapeutics | 89bio vs. Arcellx | 89bio vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |